logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-9. Last year prevalence of ecstasy among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24-year-old age group [see all figures in this series...]

Part (ii) Males 15 to 24 in Member States with higher prevalence rates


Data are from the most recent national surveys available in each country.

The age range is from between 15 and 18 years to between 59 and 64 years. Variations in age ranges may slightly influence disparities between countries.

Czech Republic: 2004; 18–64 yrs n=3526; 18–34 yrs n=1414; 18–24 yrs n=586
Estonia: 2003; 15–64 yrs n=; 15–34 yrs n=646; 15–24 yrs n=329
Ireland: 2006/07; 15–64 yrs n=4967; 15–34 yrs n=1989; 15–24 yrs n =
Spain: 2005/06; 15–64 yrs n=27934; 15–34 yrs n=14699; 15–24 yrs n=8188
Hungary: 2003; 18–54 yrs n=; 18–34 yrs n=2319; 18–24 yrs n=943
Netherlands: 2005; 15–64 yrs n=4516; 15–34 yrs n=; 15–24 yrs n=
Slovakia: 2006; 15–64 yrs n=1305; 15–34 yrs n=556; 15–24 yrs n=287
UK (E&W): 2006/07; 16–59 yrs n=31054; 16–34 yrs n=11973; 16–24 yrs n=5749

Related links:

See also Tables GPS-10, GPS-11 and GPS-18

See also 'General notes for interpreting data' on the Explanatory notes and help page


Reitox national reports 2007, taken from population surveys, reports or scientific articles.

(see the help page for information about formats etc.)

Page last updated: Tuesday, 15 July 2008